A Randomized Controlled Trial Comparing Two Different Schedules for Cisplatin Treatment in Patients with Locoregionally Advanced Nasopharyngeal Cancer

Xia, WX; Lv, X; Liang, H; Liu, GY; Sun, R; Zeng, Q; Li, SW; Mo, HY; Han, F; Luo, DH; Liu, Q; Shi, MY; Ye, YF; Yang, J; Ke, LR; Qiang, MY; Qiu, WZ; Yu, YH; Liu, KY; Huang, XJ; Li, WZ; Lv, SH; Cai, ZC; Miao, JJ; Guo, L; Chen, MY; Cao, KJ; Wang, L; Zhao, C; Huang, PY; Chen, QY; Hua, YJ; Tang, LQ; Qian, CN; Mai, HQ; Guo, X; Xiang, YQ

Mai, HQ; Guo, X (corresponding author), Sun Yat Sen Univ, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Ctr Canc, Guangzhou, Guangdong, Peoples R China.; Mai, HQ; Guo, X (corresponding author), Sun Yat Sen Univ, State Key Lab Oncol South China, Guangdong Key Lab Nasopharyngeal Carcinoma Diag &, Collaborat Innovat Ctr Canc Med,Canc Ctr, Guangzhou, Guangdong, Peoples R China.; Xiang, YQ (corresponding author), Sun Yat Sen Univ, Ctr Canc, Dept Nasopharyngeal Carcinoma, 651 Dongf

CLINICAL CANCER RESEARCH, 2021; 27 (15): 4186

Abstract

Purpose: Previous studies suggest that a cumulative cisplatin dose of 200 mg,/m(2) might be adequate in the intensity-modulated radiation therapy (IMR......

Full Text Link